本文選題：醫(yī)藥企業(yè) + 社會(huì)責(zé)任�。� 參考：《蘇州大學(xué)》2015年碩士論文

【摘要】：近來(lái)我國(guó)醫(yī)藥傷害事件頻發(fā),醫(yī)藥企業(yè)的社會(huì)責(zé)任問題引起人們的廣泛關(guān)注。本文通過(guò)我國(guó)醫(yī)藥企業(yè)社會(huì)責(zé)任的現(xiàn)狀研究,從社會(huì)組織角度分析其所存在問題,主要表現(xiàn)為：法律法規(guī)寬泛籠統(tǒng),缺乏約束力；行業(yè)協(xié)會(huì)自身利益與公眾利益沖突；媒體公信力與短期利益沖突：社會(huì)責(zé)任信息批露不暢,行業(yè)治理困難：醫(yī)藥市場(chǎng)信息不對(duì)稱,消費(fèi)者獲得相關(guān)信息困難。并依據(jù)企業(yè)社會(huì)責(zé)任理論及治理理論,進(jìn)行深入分析,提出了我國(guó)社會(huì)組織推進(jìn)企業(yè)履行企業(yè)社會(huì)責(zé)任的基本思路：完善激勵(lì)機(jī)制,推進(jìn)企業(yè)自行履行社會(huì)責(zé)任；加強(qiáng)行業(yè)協(xié)會(huì)的引導(dǎo)和監(jiān)督；增強(qiáng)其它NGO組織的介入能力：強(qiáng)化社會(huì)輿論的監(jiān)督作用；完善醫(yī)藥企業(yè)社會(huì)責(zé)任信息披露,增強(qiáng)醫(yī)藥企業(yè)治理。
[Abstract]:In recent years, medical injury incidents occur frequently in China, and the issue of social responsibility of pharmaceutical enterprises has attracted wide attention. This paper analyzes the existing problems from the angle of social organization through the research on the current situation of the social responsibility of pharmaceutical enterprises in our country. The main manifestations are as follows: broad and general laws and regulations, lack of binding force, conflicts between the interests of trade associations and public interests; Media credibility and short-term interest conflict: social responsibility information disclosure, industry governance difficulties: pharmaceutical market information asymmetry, consumer access to relevant information difficulties. On the basis of the theory of corporate social responsibility and the theory of corporate governance, the author puts forward the basic ideas of social organization in China to promote enterprises to fulfill corporate social responsibility: to perfect the incentive mechanism and to promote the enterprises to fulfill their own social responsibility; We should strengthen the guidance and supervision of trade associations, strengthen the intervention ability of other NGO organizations, strengthen the supervisory role of public opinion, perfect the disclosure of social responsibility information of pharmaceutical enterprises, and strengthen the governance of pharmaceutical enterprises.
【學(xué)位授予單位】：蘇州大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2015
【分類號(hào)】：D632.9;F426.72

【參考文獻(xiàn)】

相關(guān)期刊論文 前6條

1 胡令;;企業(yè)社會(huì)責(zé)任的經(jīng)濟(jì)學(xué)研究綜述[J];湖南廣播電視大學(xué)學(xué)報(bào);2007年02期

2 曹陽(yáng);蘇文華;;醫(yī)藥企業(yè)社會(huì)責(zé)任評(píng)價(jià)的實(shí)證研究[J];經(jīng)濟(jì)研究導(dǎo)刊;2013年09期

3 肇暉;;對(duì)醫(yī)藥企業(yè)社會(huì)責(zé)任的思考[J];上海醫(yī)藥;2011年01期

4 董麗;吳琪揚(yáng);謝霞;鄧雪嬌;;企業(yè)社會(huì)責(zé)任信息披露與市場(chǎng)地位相關(guān)性研究——來(lái)自食品飲料與醫(yī)藥行業(yè)的證據(jù)[J];統(tǒng)計(jì)與信息論壇;2009年11期

5 林賢豐;肖冬冬;劉文悅;劉嬋娟;;醫(yī)藥企業(yè)社會(huì)責(zé)任現(xiàn)狀分析及模型重建[J];醫(yī)學(xué)與社會(huì);2011年07期

6 孫超;劉俊榮;;“企業(yè)公民”與醫(yī)藥事業(yè)的境界[J];醫(yī)學(xué)與哲學(xué)(人文社會(huì)醫(yī)學(xué)版);2007年07期

，

本文編號(hào)：1828360